Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: JAMA Ophthalmol. 2013 Feb;131(2):147–153. doi: 10.1001/jamaophthalmol.2013.778

Table 3.

Univariate analyses predicting change in BSCVA (logMAR) at 3 months

Coefficient Standard Error 95% Confidence
Interval
P-Valuea
Invasive (vs. Cytotoxic)b 0.350 0.155 0.041 to 0.659 0.03
Percent Invasivenessc 0.216 0.094 0.030 to 0.402 0.02
Percent Cytotoxicityd −0.292 0.105 −0.501 to −0.083 0.007
a

P-value obtained using Huber robust regression

b

Atypical strains excluded (N=74)

c

Percent invasiveness expressed as a decimal. Gentamicin and amikacin resistant strains excluded (N=96)

d

Percent cytotoxicity expressed as a decimal. All confirmed P. aeruginosa isolates included (N=101)